+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular Diagnostics), By Application (Oncology, Nutritional & Metabolic Disease), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 125 Pages
  • April 2024
  • Region: Global
  • Grand View Research
  • ID: 5712527
Description Jump to:

Laboratory Developed Tests Market Growth & Trends

The global laboratory developed tests market size is expected to reach USD 19.85 billion by 2030, expanding at a CAGR of 7.05% from 2024 to 2030. The growth of the industry is attributed to the increasing prevalence of chronic and genetic diseases, infectious & autoimmune diseases, and rising awareness among the population about healthy living. The laboratory-developed tests (LDTs) are generated and utilized in the laboratories, and LDTs are released into the market without FDA approval or any other independent regulatory assessment. LDTs are most typically employed in molecular diagnostics, which includes tests that target a variety of different chemicals in addition to genetics.

For instance, in July 2022, Quest Diagnostics launched a lab-based molecular diagnostic test for the diagnosis of monkeypox virus infections. Moreover, immunoassay is gaining immense adoption and acceptability with the development of novel tests. For instance, in December 2021, OPKO Health, Inc., announced the FDA approval of the 4Kscore test, an LDT in which, four immunoassays are combined into a single numerical score that takes into account the patient’s age, biopsy history, and the results of a digital rectal exam. Although LDTs do not require FDA approval as they are not marketed to others, they need to go through rigorous validation procedures. However, the increasing global prevalence of cancer is a key factor driving the industry's growth.

According to GLOBOCAN, in 2020, there were an estimated 19.3 million new cancer cases globally, out of which, 2.3 million were breast cancer cases. Lung cancer was the most common cause of death among cancer patients, representing an unmet need for faster and more accurate diagnostic tools in the segment. In January 2021, the British In Vitro Diagnostics Association urged NHS England for the development of a commissioning framework for molecular diagnostics in oncology. Key players focus on product launches and geographical expansion to gain a higher industry share. For instance, in May 2022, Guardant Health launched Shield, a blood test that is available as an LDT for the detection of early signs of colorectal cancer in the adult population aged above 45 years

Laboratory Developed Tests Market Report Highlights

  • The molecular diagnostic technology segment dominated the industry and accounted for the largest share of the overall revenue in 2023
  • The segment growth was attributed to the increased need to provide diagnostics tests for a number of diseases
  • The oncology application segment is expected to grow lucratively over the forecast period due to the increasing prevalence of cancer
  • The market is expected to grow significantly owing to the introduction of innovative services that can address the growing demands of the target audience
  • North America dominated the industry in 2023 owing to the introduction of novel LDT products and the high demand for diagnostics tools with the increasing geriatric population

Table of Contents

Chapter 1. Laboratory Developed Tests Market: Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal Database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Laboratory Developed Tests Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Laboratory Developed Tests Market: Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for in vitro diagnostic tests that are currently unavailable in the market
3.2.1.2. Increasing demand for development of personalized medicine
3.2.1.3. No requirement for any regulatory approval
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with the laboratory-developed test
3.2.2.2. Efficacy and safety issues related to LDT
3.3. Laboratory Developed Tests (LDT) Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Laboratory Developed Tests (LDT) Market: Technology Estimates & Trend Analysis
4.1. Technology Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Laboratory Developed Tests (LDT) Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Immunoassays
4.4.1.1. Immunoassays market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Hematology and Coagulation
4.4.2.1. Hematology and coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Molecular Diagnostics
4.4.3.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Microbiology
4.4.4.1. Microbiology market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5. Clinical Chemistry
4.4.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.6. Histology/Cytology
4.4.6.1. Histology/Cytology market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.7. Flow Cytometry
4.4.7.1. Flow Cytometry market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.8. Mass Spectroscopy
4.4.8.1. Mass spectroscopy market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.9. Others
4.4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Laboratory Developed Tests (LDT) Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Laboratory Developed Tests (LDT) Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Oncology
5.4.1.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Genetic Disorders/Inherited Disease
5.4.2.1. Genetic disorders/Inherited disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3. Infectious & Parasitic Diseases
5.4.3.1. Infectious & parasitic diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.4. Immunology
5.4.4.1. Immunology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.5. Endocrine
5.4.5.1. Endocrine market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.6. Nutritional & Metabolic Disease
5.4.6.1. Nutritional & metabolic disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.7. Cardiology
5.4.7.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.8. Mental/Behavioral Disorder
5.4.8.1. Mental/Behavioral disorder market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.9. Pediatrics-specific Testing
5.4.9.1. Pediatrics-specific testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.10. Hematology/General Blood Testing
5.4.10.1. Hematology/General blood testing market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.11. Bodily Fluid Analysis
5.4.11.1. Bodily fluid analysis market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.12. Toxicology
5.4.12.1. Toxicology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.13. Other Diseases
5.4.13.1. Other diseases market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Laboratory Developed Tests (LDT) Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Quest Diagnostics Incorporated.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. 23andMe, Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Abbott
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Guardant Health
7.3.7.1. Company overview
7.3.7.2. Product benchmarking
7.3.7.3. Strategic initiatives
7.3.8. NeoGenomics Laboratories.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. QIAGEN
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Siemens Healthineers AG
7.3.10.1. Company overview
7.3.10.2. Product benchmarking
7.3.10.3. Strategic initiatives
7.3.11. Illumina, Inc.
7.3.11.1. Company overview
7.3.11.2. Product benchmarking
7.3.11.3. Strategic initiatives
7.3.12. F. Hoffmann-La Roche Ltd.
7.3.12.1. Company overview
7.3.12.2. Product benchmarking
7.3.12.3. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America laboratory developed tests market, by region, 2018 - 2030 (USD Million)
Table 3 North America laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 4 North America laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 6 U.S. laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 7 Canada laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 8 Canada laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 9 Europe laboratory developed tests market, by region, 2018 - 2030 (USD Million)
Table 10 Europe laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 11 Europe laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 12 Germany laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 13 Germany laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 14 U.K. laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 15 U.K. laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 16 France laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 17 France laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 18 Italy laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 19 Italy laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 20 Spain laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 21 Spain laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 22 Denmark laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 23 Denmark laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 24 Sweden laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 25 Sweden laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 26 Norway laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 27 Norway laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 28 Asia Pacific laboratory developed tests market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 30 Asia Pacific laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 31 China laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 32 China laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 33 Japan laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 34 Japan laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 35 India laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 36 India laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 37 South Korea laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 38 South Korea laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 39 Australia laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 40 Australia laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 41 Thailand laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 42 Thailand laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 43 Latin America laboratory developed tests market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 45 Latin America laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 46 Brazil laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 47 Brazil laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 48 Mexico laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 49 Mexico laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 50 Argentina laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 51 Argentina laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 52 MEA laboratory developed tests market, by region, 2018 - 2030 (USD Million)
Table 53 MEA laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 54 MEA laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 55 South Africa laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 56 South Africa laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 59 UAE laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 60 UAE laboratory developed tests market, by application, 2018 - 2030 (USD Million)
Table 61 Kuwait laboratory developed tests market, by technology, 2018 - 2030 (USD Million)
Table 62 Kuwait laboratory developed tests market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Laboratory developed tests market: market outlook
Fig. 14 Tumor ablation competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Laboratory developed tests market driver impact
Fig. 20 Laboratory developed tests market restraint impact
Fig. 21 Laboratory developed tests market strategic initiatives analysis
Fig. 22 Laboratory developed tests market: Technology movement analysis
Fig. 23 Laboratory developed tests market: Technology outlook and key takeaways
Fig. 24 Immunoassays market estimates and forecast, 2018 - 2030
Fig. 25 Hematology and coagulation estimates and forecast, 2018 - 2030
Fig. 26 Molecular diagnostics market estimates and forecast, 2018 - 2030
Fig. 27 Microbiology market estimates and forecast, 2018 - 2030
Fig. 28 Clinical chemistry market estimates and forecast, 2018 - 2030
Fig. 29 Histology/Cytology market estimates and forecast, 2018 - 2030
Fig. 30 Flow cytometry market estimates and forecast, 2018 - 2030
Fig. 31 Mass spectroscopy market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 Laboratory developed tests market: Application movement Analysis
Fig. 34 Laboratory developed tests market: Application outlook and key takeaways
Fig. 35 Oncology market estimates and forecasts, 2018 - 2030
Fig. 36 Genetic disorders/Inherited disease market estimates and forecasts, 2018 - 2030
Fig. 37 Infectious & parasitic diseases market estimates and forecasts, 2018 - 2030
Fig. 38 Immunology market estimates and forecasts, 2018 - 2030
Fig. 39 Endocrine market estimates and forecasts, 2018 - 2030
Fig. 40 Nutritional & metabolic disease market estimates and forecasts, 2018 - 2030
Fig. 41 Cardiology market estimates and forecasts, 2018 - 2030
Fig. 42 Mental/Behavioral disorder market estimates and forecasts, 2018 - 2030
Fig. 43 Pediatrics-specific testing market estimates and forecasts, 2018 - 2030
Fig. 44 Hematology/General blood testing market estimates and forecasts, 2018 - 2030
Fig. 45 Bodily fluid analysis market estimates and forecasts, 2018 - 2030
Fig. 46 Toxicology market estimates and forecasts, 2018 - 2030
Fig. 47 Other diseases market estimates and forecasts, 2018 - 2030
Fig. 48 Global laboratory developed tests market: Regional movement analysis
Fig. 49 Global laboratory developed tests market: Regional outlook and key takeaways
Fig. 50 Global laboratory developed tests market share and leading players
Fig. 51 North America market share and leading players
Fig. 52 Europe market share and leading players
Fig. 53 Asia Pacific market share and leading players
Fig. 54 Latin America market share and leading players
Fig. 55 Middle East & Africa market share and leading players
Fig. 56 North America: SWOT
Fig. 57 Europe SWOT
Fig. 58 Asia Pacific SWOT
Fig. 59 Latin America SWOT
Fig. 60 MEA SWOT
Fig. 61 North America market estimates and forecasts, 2018 - 2030
Fig. 62 U.S key country dynamics
Fig. 63 U.S market estimates and forecasts, 2018 - 2030
Fig. 64 Canada key country dynamics
Fig. 65 Canada market estimates and forecasts, 2018 - 2030
Fig. 66 Europe market estimates and forecasts, 2018 - 2030
Fig. 67 UK key country dynamics
Fig. 68 UK market estimates and forecasts, 2018 - 2030
Fig. 69 Germany key country dynamics
Fig. 70 Germany market estimates and forecasts, 2018 - 2030
Fig. 71 France key country dynamics
Fig. 72 France market estimates and forecasts, 2018 - 2030
Fig. 73 Italy key country dynamics
Fig. 74 Italy market estimates and forecasts, 2018 - 2030
Fig. 75 Spain key country dynamics
Fig. 76 Spain market estimates and forecasts, 2018 - 2030
Fig. 77 Denmark key country dynamics
Fig. 78 Denmark market estimates and forecasts, 2018 - 2030
Fig. 79 Sweden key country dynamics
Fig. 80 Sweden market estimates and forecasts, 2018 - 2030
Fig. 81 Norway key country dynamics
Fig. 82 Norway market estimates and forecasts, 2018 - 2030
Fig. 83 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 84 China key country dynamics
Fig. 85 China market estimates and forecasts, 2018 - 2030
Fig. 86 Japan key country dynamics
Fig. 87 Japan market estimates and forecasts, 2018 - 2030
Fig. 88 India key country dynamics
Fig. 89 India market estimates and forecasts, 2018 - 2030
Fig. 90 Thailand key country dynamics
Fig. 91 Thailand market estimates and forecasts, 2018 - 2030
Fig. 92 South Korea key country dynamics
Fig. 93 South Korea market estimates and forecasts, 2018 - 2030
Fig. 94 Australia key country dynamics
Fig. 95 Australia market estimates and forecasts, 2018 - 2030
Fig. 96 Latin America market estimates and forecasts, 2018 - 2030
Fig. 97 Brazil key country dynamics
Fig. 98 Brazil market estimates and forecasts, 2018 - 2030
Fig. 99 Mexico key country dynamics
Fig. 100 Mexico market estimates and forecasts, 2018 - 2030
Fig. 101 Argentina key country dynamics
Fig. 102 Argentina market estimates and forecasts, 2018 - 2030
Fig. 103 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 104 South Africa key country dynamics
Fig. 105 South Africa market estimates and forecasts, 2018 - 2030
Fig. 106 Saudi Arabia key country dynamics
Fig. 107 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 108 UAE key country dynamics
Fig. 109 UAE market estimates and forecasts, 2018 - 2030
Fig. 110 Kuwait key country dynamics
Fig. 111 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 112 Market share of key market players- Laboratory developed tests market

Companies Mentioned

  • Quest Diagnostics Incorporated.
  • 23andMe, Inc.
  • Abbott
  • Guardant Health
  • NeoGenomics Laboratories.
  • QIAGEN
  • Siemens Healthineers AG
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages125
PublishedApril 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 12.36 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.85 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry), By Service Provider, By Application, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry), By Service Provider, By Application, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Pathology Laboratories Market Size, Share & Trends Analysis Report by Type (Hospital-based, Standalone Labs), Testing Services (General Physiological & Clinical Tests, COVID-19 Test), End-use (Physician Referrals), Region, and Segment Forecasts, 2025-2030 - Product Image

Pathology Laboratories Market Size, Share & Trends Analysis Report by Type (Hospital-based, Standalone Labs), Testing Services (General Physiological & Clinical Tests, COVID-19 Test), End-use (Physician Referrals), Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028 - Product Image

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028

  • Report
  • 260 Pages
  • Global
From
Clinical Laboratory Tests Market by Test Type, Indication, End-User - Global Forecast 2025-2030 - Product Image

Clinical Laboratory Tests Market by Test Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
The Worldwide Market for Clinical Laboratory Services, 9th Edition - Product Image

The Worldwide Market for Clinical Laboratory Services, 9th Edition

  • Report
  • 250 Pages
  • Global
From

About the Laboratory Developed Test Market

The Laboratory Developed Test (LDT) market is a subset of the laboratory testing industry. It is composed of tests that are designed, manufactured, and used within a single laboratory. These tests are not subject to the same regulatory requirements as tests that are commercially available. LDTs are often used to diagnose rare diseases, detect genetic mutations, and monitor therapeutic response. LDTs are typically used in clinical settings, such as hospitals and physician offices, and are often used to supplement or replace commercially available tests. They are also used in research settings to develop new tests and to validate existing tests. The LDT market is highly competitive, with many companies offering a wide range of tests. Some of the major players in the market include Quest Diagnostics, LabCorp, ARUP Laboratories, Mayo Medical Laboratories, and Eurofins Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.